Literature DB >> 14618271

Nuclear localization of mouse fibroblast growth factor 2 requires N-terminal and C-terminal sequences.

A Foletti1, F Vuadens, F Beermann.   

Abstract

In vertebrates, different isoforms of fibroblast growth factor 2 (FGF2) exist, which differ by their N-terminal extension. They show different localization and expression levels and exert distinct biological effects. Nevertheless, genetic inactivation of all FGF2 isoforms in the mouse results in only mild phenotypes. Here, we analyzed mouse FGF2, and show that, as in the human, mouse FGF2 contains CTG-initiated high molecular-weight (HMW) isoforms, which contain a nuclear localization signal, and which mediate localization of this isoform to the nucleus. Using green fluorescent protein-FGF2 fusions, we furthermore observed, that C-terminal deletions disable nuclear localization of the short low-molecular-weight (LMW) 18-kDa isoform. This loss of specific localization is accompanied by a loss in heparin binding. We therefore suggest that, first, localization of mouse FGF2 is comparable to that in other vertebrates and, second, FGF2 contains at least two sequences important for nuclear localization, a nuclear localization sequence at the N terminus which is only contained in the HMW isoform, and another sequence at the C terminus, which is only required for localization of the LMW 18-kDa isoform.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618271     DOI: 10.1007/s00018-003-3258-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  18 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

2.  Echocardiographic and angiographic evaluation of left ventricular function during percutaneous transluminal aortic valvuloplasty.

Authors:  S Sack; K J Henrichs; R Erbel; N Wittlich; J Meyer
Journal:  Cathet Cardiovasc Diagn       Date:  1992-06

3.  Valve implantation on the beating heart: catheter-assisted surgery for aortic stenosis.

Authors:  Sabine Bleiziffer; Hendrik Ruge; Domenico Mazzitelli; Christian Schreiber; Andrea Hutter; Markus Krane; Robert Bauernschmitt; Rüdiger Lange
Journal:  Dtsch Arztebl Int       Date:  2009-04-03       Impact factor: 5.594

4.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

5.  Risk of patients with severe aortic stenosis undergoing noncardiac surgery.

Authors:  L C Torsher; C Shub; S R Rettke; D L Brown
Journal:  Am J Cardiol       Date:  1998-02-15       Impact factor: 2.778

6.  Transapical transcatheter aortic valve implantation in humans: initial clinical experience.

Authors:  Samuel V Lichtenstein; Anson Cheung; Jian Ye; Christopher R Thompson; Ronald G Carere; Sanjeevan Pasupati; John G Webb
Journal:  Circulation       Date:  2006-07-31       Impact factor: 29.690

7.  Observed and relative survival after aortic valve replacement.

Authors:  P Kvidal; R Bergström; L G Hörte; E Ståhle
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

8.  Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival.

Authors:  E B Lieberman; T M Bashore; J B Hermiller; J S Wilson; K S Pieper; G P Keeler; C H Pierce; K B Kisslo; J K Harrison; C J Davidson
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

9.  Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry.

Authors: 
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

10.  Abrupt homeostatic responses to transient intracardiac occlusion during balloon valvuloplasty.

Authors:  J Suárez de Lezo; P Montilla; M Pan; M Romero; M Sancho; J Ruiz de Castroviejo; I Tejero; J Arizón; J L Carrasco
Journal:  Am J Cardiol       Date:  1989-09-01       Impact factor: 2.778

View more
  4 in total

Review 1.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

2.  Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice.

Authors:  Laurence Guyonneau; Fabien Murisier; Anita Rossier; Alexandre Moulin; Friedrich Beermann
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 3.  Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Authors:  Siyun Liao; Janet Bodmer; Daniel Pietras; Mohamad Azhar; Tom Doetschman; Jo El J Schultz
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

4.  Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.

Authors:  Nathalie Planque
Journal:  Cell Commun Signal       Date:  2006-10-18       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.